Page last updated: 2024-08-23

paclitaxel and s 1743

paclitaxel has been researched along with s 1743 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Abadie-Lacourtoisie, S; Capitain, O; Lortholary, A1
Bae, DS; Choi, CH; Choi, JJ; Hong, JE; Jeon, HK; Kim, BG; Kim, TJ; Lee, JW; Song, T1
Chen, Y; He, J; Li, ZL; Li, ZM; Pan, XH; Shi, XY; Xiao, L; Yan, SJ1
Bai, Z; Ding, N; Ge, J; Liu, X; Wang, L; Wang, Y; Wei, Q; Wu, N; Xu, S; Zhou, G1

Other Studies

4 other study(ies) available for paclitaxel and s 1743

ArticleYear
[Cytolytic hepatitis and esomeprazole during chemotherapy].
    Presse medicale (Paris, France : 1983), 2005, Oct-08, Volume: 34, Issue:17

    Topics: Adult; Anti-Ulcer Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemical and Drug Induced Liver Injury; Esomeprazole; Esophagitis; Female; Humans; Paclitaxel; Trastuzumab

2005
Proton Pump Inhibition Enhances the Cytotoxicity of Paclitaxel in Cervical Cancer.
    Cancer research and treatment, 2017, Volume: 49, Issue:3

    Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Drug Synergism; Esomeprazole; Female; Gene Expression; Humans; Immunohistochemistry; Paclitaxel; Proton Pump Inhibitors; Proton Pumps; RNA Interference; RNA, Small Interfering; Uterine Cervical Neoplasms; Vacuolar Proton-Translocating ATPases

2017
Proton pump inhibitors can reverse the YAP mediated paclitaxel resistance in epithelial ovarian cancer.
    BMC molecular and cell biology, 2019, 11-12, Volume: 20, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Drug Resistance, Neoplasm; Esomeprazole; Female; Humans; Ovarian Neoplasms; Paclitaxel; Proton Pump Inhibitors; Transcription Factors; Tumor Microenvironment; Vacuolar Proton-Translocating ATPases; YAP-Signaling Proteins

2019
Esomeprazole overcomes paclitaxel-resistance and enhances anticancer effects of paclitaxel by inducing autophagy in A549/Taxol cells.
    Cell biology international, 2021, Volume: 45, Issue:1

    Topics: A549 Cells; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Cell Cycle Checkpoints; Cell Proliferation; Drug Resistance, Neoplasm; Esomeprazole; Humans; Paclitaxel; Up-Regulation; Vacuolar Proton-Translocating ATPases

2021
chemdatabank.com